Clinical Trial Update: Treatment With Octreotide in Patients With Lymphangioleiomyomatosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating octreotide in patients with lymphangioleiomyomatosis was completed, with results posted in 2010. The sponsor was the National Heart, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lymphangioleiomyomatosis, Lymphangiomyomas | Phase 2 | Status: COMPLETED | Results posted: 2010-04-30